Oral Vaccine Market Growth Through 2030 Creates New Strategic Opportunities
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Oral Vaccine Market Size, Value And Growth Trends Through 2030
The oral vaccine market has experienced notable expansion in recent years, with its value projected to rise from $3.95 billion in 2025 to $4.35 billion in 2026, reflecting a compound annual growth rate (CAGR) of 10.0%. This historical growth has been driven by factors such as the widespread occurrence of diseases that can be prevented through vaccination, increased public awareness regarding the advantages of immunization, implementation of government-led vaccination campaigns, advancements in oral vaccines for polio and cholera, and the expansion of vaccination services within hospitals and clinics.
The oral vaccine market is projected to experience robust expansion over the coming years, with its value anticipated to reach $6.29 billion by 2030, reflecting a compound annual growth rate (CAGR) of 9.7%. This forecasted growth is driven by several key factors, including the emergence of novel oral vaccines based on DNA, RNA, and virus-like particles (VLPs), the broadening of global immunization initiatives, the incorporation of digital health and monitoring technologies, heightened investment in vaccine R&D, and an increased emphasis on vaccinations for adults and travelers. Among the notable trends shaping the market are the growing use of oral vaccines for childhood immunization, a stronger focus on preventive care and large-scale vaccination drives, the advancement of live attenuated and subunit oral vaccines, the expansion of government-supported immunization programs, and the implementation of improvements in cold chain and logistics to facilitate vaccine distribution.
Download A Free Sample Report For Comprehensive Market Insights:
Oral Vaccine Market Development Factors: Which Trends Are Supporting Demand?
The ongoing increase in infectious disease cases is anticipated to drive expansion in the oral vaccine market moving forward. Infectious diseases, caused by harmful microorganisms like bacteria, viruses, fungi, or parasites, are transmitted between people or via environmental exposure. Their prevalence is growing partly due to heightened global travel, which facilitates the swift cross-border movement of individuals and pathogens, thereby accelerating worldwide infection spread. Oral vaccines prove advantageous against such diseases by inducing mucosal immunity within the gut—a key entry site for numerous pathogens—thus delivering effective protection at the infection point. As an illustration, data from the Health Security Agency, a UK government body, released in May 2025, revealed that reported tuberculosis (TB) cases in England in 2023 rose by 11.0% compared to 2022. Consequently, the rising incidence of infectious diseases is fueling growth in the oral vaccine market.
Oral Vaccine Market Segmentation: How Is The Market Structured Across Key Categories?
The oral vaccine market covered in this report is segmented –
1) By Vaccine Type: Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Other Vaccine Types
2) By Application: Polio, Cholera, Other Applications
3) By End-User: Hospital , Clinics, Government Organization, Other End-Users
Subsegments:
1) By Live Attenuated Vaccines: Oral Polio Vaccine (OPV), Rotavirus Vaccine, Oral Typhoid Vaccine, Oral Cholera Vaccine
2) By Inactivated Vaccines: Inactivated Polio Vaccine (IPV), Inactivated Cholera Vaccine, Inactivated Hepatitis A Vaccine
3) By Subunit Vaccines: Protein Subunit Vaccines, Polysaccharide Vaccines, Conjugate Vaccines
4) By Other Vaccine Types: Virus-Like Particle (VLP) Vaccines, Recombinant Vector Vaccines
Oral Vaccine Market Transformation Trends: Which Innovations Are Driving Change?
Key players in the oral vaccine sector are concentrating their efforts on pioneering advanced solutions, like next-generation oral pill vaccines, aimed at boosting immune reactions and simplifying administration. This type of pill-based oral vaccine, developed as a second-generation product, seeks to increase immunogenicity, extend coverage, and facilitate large-scale vaccination campaigns while eliminating dependence on needles or cold-chain requirements. In March 2025, Vaxart Inc., a biotechnology firm headquartered in the United States, revealed the launch of a Phase 1 clinical trial for its updated oral norovirus vaccine delivered as a pill. This study is designed to assess enhanced immune responses and safety attributes of the refined formulations, with a focus on addressing the persistent global demand for effective and easily accessible norovirus immunization. The tablet format helps overcome obstacles typical of injectable vaccines, supporting swift and widespread distribution, especially during outbreak scenarios.
Oral Vaccine Market Competitive Landscape And Leading Companies
Major companies operating in the oral vaccine market are Panacea Biotec Ltd., Zydus Lifesciences, Serum Institute of India Pvt. Ltd., Bharat Biotech Ltd., Haffkine Biopharmaceutical Co. Ltd., Medigen Vaccine Biologics Corp., BlueWillow Biologics Inc.
Access The Complete Oral Vaccine Market Report:
Oral Vaccine Market Geographic Analysis: Where Is Demand Growing The Fastest?
North America was the largest region in the oral vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oral vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
